THE RISK LEVEL OF VIET NAM MEDICINE INDUSTRY UNDER FINANCIAL LEVERAGE DURING AND AFTER THE GLOBAL CRISIS 2009-2011
2018
Dinh Tran Ngoc Huy
This paperwork evaluates the impacts of external financing on market risk for the listed firms in the Viet nam medicine industry, esp. during and after the financial crisis 2009-2011. First of all, by using quantitative and analytical methods to estimate asset and equity beta of total 6 listed companies in Viet Nam medicine industry with a proper traditional model, we found out that the beta values, in general, for many institutions are acceptable. Second, under 3 different scenarios of changing leverage (in 2011 financial reports, 30% up and 20% down), we recognized that the risk level, measured by equity and asset beta mean, decreases when leverage increases to 30% but increases more if leverage decreases down to 20%. Third, by changing leverage in 3 scenarios, we recognized the dispersion of risk level, measured by equity beta var, keeping the same value of 0,711 if the leverage increases to 30% or if leverage decreases to 20%. But the dispersion measured by asset beta var increases to 0,200 (leverage down 20%), showing leverage impact. Finally, this paper provides some outcomes that could provide companies and government more evidence in establishing their policies in governance.
Afficher plus [+] Moins [-]Mots clés AGROVOC
Informations bibliographiques
Cette notice bibliographique a été fournie par Southern Caucasus Scientific Journals
Découvrez la collection de ce fournisseur de données dans AGRIS
